Children's Oncology Group's 2013 blueprint for research: cancer control and supportive care
- PMID: 23255159
- PMCID: PMC4447629
- DOI: 10.1002/pbc.24426
Children's Oncology Group's 2013 blueprint for research: cancer control and supportive care
Abstract
In cancer control research, the objective is to reduce overall morbidity and mortality by decreasing acute and delayed treatment-related toxicities in all children with cancer. To date, the Children's Oncology Group (COG) has focused on infection, neurocognition, quality of life (QoL), and nutrition/antiemetics. COG is conducting randomized controlled trials (RCTs) to determine prophylaxis strategies that will reduce infections in high-risk populations. Two RCTs are determining if modafinil or computerized cognitive training improve cognitive functioning in pediatric brain tumor patients. QoL is being assessed in acute leukemia patients. Improved supportive care outcomes will only occur when the most effective interventions are established.
Copyright © 2012 Wiley Periodicals, Inc.
References
-
- Sung L, Lange BJ, Gerbing RB, et al. Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia. Blood. 2007;110:3532–3539. - PubMed
-
- Sung L, Aplenc R, Alonzo TA, et al. Severe toxicities during pediatric acute myeloid leukemia chemotherapy: A report from the Children’s Oncology Group. Abstract presented at: American Society of Hematology Conference; December 2010; Orlando, Florida.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
